English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/81662
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

MYC oncogene in myeloid neoplasias

AuthorsDelgado, M. Dolores ; Albajar, Marta ; Gómez-Casares, M. Teresa; Batlle-López, Ana; León, Javier
KeywordsMYC
Myeloid neoplasia
Acute myeloid leukemia
Issue Date2013
PublisherSpringer
CitationClinical and Translational Oncology 15(2): 87-94 (2013)
AbstractMYC is a transcription factor that regulates many critical genes for cell proliferation, differentiation, and biomass accumulation. MYC is one of the most prevalent oncogenes found to be altered in human cancer, being deregulated in about 50 % of tumors. Although MYC deregulation has been more frequently associated to lymphoma and lymphoblastic leukemia than to myeloid malignancies, a body of evidence has been gathered showing that MYC plays a relevant role in malignancies derived from the myeloid compartment. The myeloid leukemogenic activity of MYC has been demonstrated in different murine models. Not surprisingly, MYC has been found to be amplified or/and deregulated in the three major types of myeloid neoplasms: acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms, including chronic myeloid leukemia. Here, we review the recent literature describing the involvement of MYC in myeloid tumors. © 2012 Federación de Sociedades Españolas de Oncología (FESEO).
URIhttp://hdl.handle.net/10261/81662
DOI10.1007/s12094-012-0926-8
Identifiersdoi: 10.1007/s12094-012-0926-8
issn: 1699-048X
e-issn: 1699-3055
Appears in Collections:(IBBTEC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.